The $1,000,000 Reg A capital raise, will use the company's
Series B Preferred Shares and is expected to be completed in three
phases. Each phase will represent its own discounted percentage,
giving initial investors the advantage. The fund will provide
non-toxic funding to assist in the development and maintenance of
Canniboids as well as assist in the consolidation of past legacy
debt to provide for a more stable market. More details of the Reg A
raise will be released in the very near future.
Joe Riehl, CEO of Metatron, says, "Our main focus is producing a
quality Cannabis product for this rapidly growing industry.
Isolating Canniboids as its own subsidiary, will ensure it receives
the much needed support to be a front runner in the CBD market.
This year, analysts expect the cannabis market to produce $6.7B of
new wealth, by 2020, Bank of America and Merrill Lynch estimate
that will grow to $35 billion a year, and the New York Times
describes what's taking place as a gold rush. Metatron is eager to
take advantage of this opportunity."
Download Apps
People interested can view and download our current live apps
focused on mental health and wellness, cannabis, and message
encryption by visiting the app stores below. We plan to update
these apps in our upcoming relaunch, and will be adding a couple
more to our list.
The Company has experience in developing over 2000+ mobile
applications in the past years, with over 3.5 million in sales.
Stay tuned!
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
Forward-Looking Statements: Any statements made in this press
release which are not historical facts contain certain
forward-looking statements, as such term is defined in the Private
Litigation Reform Act of 1995, concerning potential developments
affecting the business, prospects, financial condition and other
aspects of the company to which this release pertains. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results
of the specific items described in this release, and the company's
operations generally, to differ materially from what is projected
in such forward-looking statements. Although such statements are
based upon the best judgments of management of the company as of
the date of this release, significant deviations in magnitude,
timing and other factors may result from business risks and
uncertainties including, without limitation, the company's need for
additional financing, which is not assured and which may result in
dilution of shareholders, the company's status as a small company
with a limited operating history, dependence on third parties and
the continuing popularity of the iOS operating system, general
market and economic conditions, technical factors, receipt of
revenues, and other factors, many of which are beyond the control
of the company. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot
guarantee future results, levels of activity, performance, or
achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of such
statements, and we disclaim any obligation to update information
contained in any forward looking statement. Metatron retained
Global Discovery Group Inc. for $30,500 for consulting services,
CSC Partners for $1,500, Bas1 for $2501and the company retained
Pacific Equity Alliance LLC by issuing Integrative Business
Alliance LLC 100m rule 144 for 1 year consulting services. Metatron
does not grow, sell or distribute any substances that violate
United States Law or the controlled substance act.
